After the Scripps Research Institute in Florida had new facilities installed to accommodate a massive microbial biobank it inherited from Pfizer, chemist Ben Shen eagerly welcomed the resource. It contains more than 210,000 frozen or freeze-dried microbial strains that Shen and his colleagues are now mining for natural products.
MARK VAN HOY, SCRIPPS RESEARCH INSTITUTE
SCOTT WISEMAN
SCOTT WISEMAN
Read the full story.
Jef Akst is managing editor of The Scientist. Email her at [email protected].
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?